SRRK
Scholar Rock Holding Corporation
There isn't enough reported data to score SRRK yet.
SRRK Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Weak | |
| Unavailable |
SRRK's profitability and cash flow are currently under pressure. There isn't enough data to rate its revenue and balance sheet.
SRRK PE Valuation
SRRK has no meaningful PE right now: it lost money over the past year.
SRRK Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect SRRK's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
SRRK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.22 | -$0.05 |
| Q2 2026 | -$3.31 | -$0.38 |
| Q1 2026 | -$3.45 | -$0.90 |
| Q4 2025 | -$3.29 | -$0.82 |
| Q3 2025 | -$3.17 | -$0.82 |
| Q2 2025 | -$2.93 | -$0.71 |
| Q1 2025 | -$2.55 | -$0.46 |
| Q4 2024 | -$2.47 | -$0.48 |
SRRK lost $3.22 per share over the past year, about the same as its loss the year before.
SRRK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2022 | $33.2M | +605% |
| Q4 2021 | $4M | +18% |
| Q3 2021 | $5.5M | +80% |
| Q2 2021 | $4.6M | +18% |
| Q1 2021 | $4.7M | -6.4% |
| Q4 2020 | $3.4M | -55% |
SRRK's revenue is growing: $570,000 last quarter.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -18607% | N/A |
| Q1 2022 | -21% | +557 points |
| Q4 2021 | -873% | -114 points |
| Q3 2021 | -679% | +99 points |
| Q2 2021 | -659% | -160 points |
| Q1 2021 | -578% | -226 points |
| Q4 2020 | -760% | -597 points |
| Q3 2020 | -778% | N/A |
SRRK's operating margin was −18607% last quarter, down 17948 points from the same quarter a year ago, near the bottom of its range since 2019.
SRRK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$81.9M | -$12.9M |
| Q2 2026 | -$70.3M | +$6.8M |
| Q1 2026 | -$82.2M | -$3.2M |
| Q4 2025 | -$75.5M | -$26M |
| Q3 2025 | -$69M | -$16.5M |
| Q2 2025 | -$77.2M | -$27.9M |
| Q1 2025 | -$78.9M | -$29.1M |
| Q4 2024 | -$49.5M | -$12.2M |
SRRK has burned cash in almost every quarter: −$310M over the past year, against −$275M the year before.
SRRK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.3% | +1.8M shares |
| 1 year | +16% | +18.6M shares |
| 3 years | +64% | +51.8M shares |
| 5 years | +262% | +95.8M shares |
| Available history | +381% | +105M shares |
SRRK has 132M diluted shares, up 16% from a year ago.
SRRK Net Leverage
SRRK's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
SRRK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 44.3 | Neutral |
| Stochastic | 25.9 | Neutral |
SRRK's weekly RSI is 44 (neutral) and its Stochastic is 26 (neutral).
SRRK PE vs Healthcare Sector
SRRK has no meaningful PE right now: it lost money over the past year.
SRRK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.1 | 2.2% below |
| 20 week MA | $49.5 | 13% below |
| 50 week MA | $47.5 | 9.2% below |
| 100 week MA | $41.5 | 4.1% above |
| 200 week MA | $27.1 | 59% above |
SRRK has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 59% above its 200-week average.
SRRK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $13.0 | $51.5 | +296% |
| 2021 | $51.5 | $25.4 | -51% |
| 2022 | $25.4 | $7.97 | -69% |
| 2023 | $7.97 | $18.8 | +136% |
| 2024 | $18.8 | $44.5 | +136% |
| 2025 | $44.5 | $45.7 | +2.7% |
| 2026 YTD | $45.7 | $43.2 | -5.5% |
SRRK's yearly returns have swung widely, from +296% in 2020 to −69% in 2022. It's down 5.5% so far in 2026.